AbCellera Biologics' stock surged 5.26% during intraday trading on Monday, following news of increased ownership by a significant investor.
The price movement appears to be driven by a filing revealing that Thermopylae Holdings Ltd., already a 10% owner of the company, reported an acquisition of additional common shares in AbCellera Biologics Inc. Such purchases by major shareholders are often interpreted by the market as a strong vote of confidence in the company's future prospects.